| Vascular-specific growth factors and blood vessel formation GD Yancopoulos, S Davis, NW Gale, JS Rudge, SJ Wiegand, J Holash nature 407 (6801), 242-248, 2000 | 5195 | 2000 |
| Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis PC Maisonpierre, C Suri, PF Jones, S Bartunkova, SJ Wiegand, ... Science 277 (5322), 55-60, 1997 | 4746 | 1997 |
| Identification of ubiquitin ligases required for skeletal muscle atrophy SC Bodine, E Latres, S Baumhueter, VKM Lai, L Nunez, BA Clarke, ... Science 294 (5547), 1704-1708, 2001 | 4089 | 2001 |
| Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis C Suri, PF Jones, S Patan, S Bartunkova, PC Maisonpierre, S Davis, ... Cell 87 (7), 1171-1180, 1996 | 3658 | 1996 |
| Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo SC Bodine, TN Stitt, M Gonzalez, WO Kline, GL Stover, R Bauerlein, ... Nature cell biology 3 (11), 1014-1019, 2001 | 3252 | 2001 |
| Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF J Holash, PC Maisonpierre, D Compton, P Boland, CR Alexander, ... Science 284 (5422), 1994-1998, 1999 | 3005 | 1999 |
| Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration JS Heier, DM Brown, V Chong, JF Korobelnik, PK Kaiser, QD Nguyen, ... Ophthalmology 119 (12), 2537-2548, 2012 | 2740 | 2012 |
| Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning S Davis, TH Aldrich, PF Jones, A Acheson, DL Compton, V Jain, TE Ryan, ... Cell 87 (7), 1161-1169, 1996 | 2624 | 1996 |
| ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF TG Boulton, SH Nye, DJ Robbins, NY Ip, E Radzlejewska, ... Cell 65 (4), 663-675, 1991 | 2556 | 1991 |
| The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors TN Stitt, D Drujan, BA Clarke, F Panaro, Y Timofeyva, WO Kline, ... Molecular cell 14 (3), 395-403, 2004 | 2281 | 2004 |
| VEGF-Trap: a VEGF blocker with potent antitumor effects J Holash, S Davis, N Papadopoulos, SD Croll, L Ho, M Russell, P Boland, ... Proceedings of the National Academy of Sciences 99 (17), 11393-11398, 2002 | 2197 | 2002 |
| Mediation of IGF-1-induced skeletal myotube hypertrophy by PI (3) K/Akt/mTOR and PI (3) K/Akt/GSK3 pathways C Rommel, SC Bodine, BA Clarke, R Rossman, L Nunez, TN Stitt, ... Nature cell biology 3 (11), 1009-1013, 2001 | 1939 | 2001 |
| BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra C Hyman, M Hofer, YA Barde, M Juhasz, GD Yancopoulos, SP Squinto, ... Nature 350 (6315), 230-232, 1991 | 1920 | 1991 |
| Two phase 3 trials of dupilumab versus placebo in atopic dermatitis EL Simpson, T Bieber, E Guttman-Yassky, LA Beck, A Blauvelt, MJ Cork, ... New England Journal of Medicine 375 (24), 2335-2348, 2016 | 1912 | 2016 |
| Genomic instability and aging-like phenotype in the absence of mammalian SIRT6 R Mostoslavsky, KF Chua, DB Lombard, WW Pang, MR Fischer, L Gellon, ... Cell 124 (2), 315-329, 2006 | 1896 | 2006 |
| Regulation of the germinal center response by microRNA-155 TH Thai, DP Calado, S Casola, KM Ansel, C Xiao, Y Xue, A Murphy, ... Science 316 (5824), 604-608, 2007 | 1869 | 2007 |
| REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19 DM Weinreich, S Sivapalasingam, T Norton, S Ali, H Gao, R Bhore, ... New England Journal of Medicine 384 (3), 238-251, 2021 | 1831 | 2021 |
| Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma M Castro, J Corren, ID Pavord, J Maspero, S Wenzel, KF Rabe, ... New England journal of medicine 378 (26), 2486-2496, 2018 | 1788 | 2018 |
| Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1 G Thurston, C Suri, K Smith, J McClain, TN Sato, GD Yancopoulos, ... Science 286 (5449), 2511-2514, 1999 | 1756 | 1999 |
| Neurotrophin-3: a neurotrophic factor related to NGF and BDNF PC Maisonpierre, L Belluscio, S Squinto, NY Ip, ME Furth, RM Lindsay, ... Science 247 (4949), 1446-1451, 1990 | 1705 | 1990 |
David J. GlassRegeneron PharmaceuticalsEmail verificata su regeneron.com
